I am furious

I submit this statement as a formal objection to the Department of Veterans Affairs’ recent ruling concerning the consideration of medication use in disability evaluations. Both the substance of this ruling and the manner in which it has been introduced raise serious concerns regarding its legality, fairness, and consistency with the purpose of the veterans’ disability compensation system.

The VA has a well‑documented history of issuing policy changes, assuring veterans that such changes will not be applied in an adverse manner, and then allowing those policies to remain in place—unrescinded and unresolved—until they are gradually incorporated into adjudicative practice once public scrutiny subsides. This practice of placing harmful policies into procedural limbo, rather than formally withdrawing them, has repeatedly resulted in the delayed but predictable erosion of veterans’ benefits. The present ruling fits squarely within that pattern and must be addressed accordingly.

The underlying premise of the ruling—that the use of prescribed medication reflects meaningful or sustained functional improvement—is fundamentally flawed. Pharmacological treatment does not cure or eliminate service‑connected mental or physical disabilities. It merely suppresses symptoms to a degree that may permit limited functioning. The underlying conditions, including trauma, chronic pain, and psychological injury, persist irrespective of medication compliance. Conflating symptom management with actual improvement misrepresents medical reality and improperly redefines the nature of chronic disability.

Of equal concern is the VA’s longstanding practice of initiating rating reductions based on minimal, temporary, or situational changes in a veteran’s condition. Disabilities—particularly mental health conditions and chronic illnesses—are inherently variable. Momentary stabilization, often achieved only through continuous medication and treatment, does not constitute material or sustained improvement. Nonetheless, veterans are routinely subjected to reevaluation and reduction actions based on such marginal changes, placing lawfully awarded benefits in perpetual jeopardy.

When viewed in full context, this ruling appears designed to further lower the evidentiary threshold for challenging and reducing disability ratings by treating medication‑assisted stability as improvement. This improperly shifts the burden onto veterans to repeatedly re‑prove the persistence of their disabilities and contradicts the fundamental purpose of disability compensation, which is to recognize long‑term impairment resulting from service.

For these reasons, this ruling must not merely be deferred, paused, or left unaddressed. It must be formally rescinded. Allowing it to remain in effect—unapplied in name only, yet available for future use once public opposition diminishes—would perpetuate the very harms veterans have repeatedly experienced under similar policies. Any regulation or guidance that fails to clearly distinguish between symptom management and actual improvement is inherently unjust and incompatible with good‑faith administration of veterans’ benefits.